
ASN Kidney Translation Series: Cardiovascular-Kidney-Metabolic (CKM) Syndrome Advances
0:00
1:06:22
ASN Kidney Translation explores advances in Cardiovascular-Kidney-Metabolic syndrome, including building a cardio-nephrology service (Kidney360), cardiorenal benefits of SGLT2 inhibitors & GLP-1 receptor agonists (JASN), & PREVENT risk prediction (CJASN).
More episodes from "Journal of the American Society of Nephrology (JASN)"



Don't miss an episode of “Journal of the American Society of Nephrology (JASN)” and subscribe to it in the GetPodcast app.








